Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes

2.04

SEK

1.49

percent

Q-linea as an investment

Q-linea as an investment

Welcome to the Investor Relations section. Here we have gathered important information about Q-linea for existing investors and others who are interested in our business.

NASDAQ Stockholm(QLINEA): Quotes are delayed 15 minutes

2.04

SEK

1.49

percent

Life Science Day Presentation

Our CEO Stuart Gander presented at Life Science Day courtesy of Aktiespararna on the 17th of April 2024.

Watch the presentation here:

 

 

Future-proof Healthcare

One of our founders, Jonas Jarvius explains how Q-linea is intimately tied to his experiences of healthcare inequity, and how Q-linea is working to ensure we have sustainable and equitable healthcare, now and in the future.

 

 

Press releases

Regulatory press release

2024/04/12

Q-linea publish the Annual report for 2023

Press release

2024/03/13

Strong ASTar results presented at AMCLI

Press release

2024/03/05

Q-linea participates in tender for rapid AST
The region of Tuscany in Italy has announced a tender for rapid AST instruments and consumables which Q-linea will…
Read more >

Keep up to date – subscribe

Christer Samuelsson

Investor Relations

Phone: +46 18 444 36 10

Mobile: +46 70 600 15 20

christer.samuelsson@qlinea.com

. . .
The share

Information about Q-linea stock price and trading volume